Literature DB >> 6262917

Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary.

M Berelowitz, M Szabo, L A Frohman, S Firestone, L Chu, R L Hintz.   

Abstract

Somatomedin-C stimulates somatostatin release to a maximum of 390 percent of basal release during short-term (20-minute) incubation of rat hypothalamus. It has no effect on basal or stimulated growth hormone release from primary cultures of rat adenohypophyseal cells during a 4-hour incubation, but inhibits stimulated release by more that 90 percent after 24 hours. These findings suggest that somatomedin-C participates in the growth hormone negative feedback loop with an immediate effect on hypothalamic somatostatin and a delayed effect on the anterior pituitary.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262917     DOI: 10.1126/science.6262917

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  90 in total

1.  Growth hormone levels in relation to birth weight and gestational age.

Authors:  G D Rajesh; B V Bhat; M G Sridhar; P Ranganathan
Journal:  Indian J Pediatr       Date:  2000-03       Impact factor: 1.967

Review 2.  Thyroid hormones and growth hormone secretion.

Authors:  R Valcavi; M Zini; I Portioli
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

Review 3.  The role of growth factors in the pituitary.

Authors:  S Ezzat; S Melmed
Journal:  J Endocrinol Invest       Date:  1990-09       Impact factor: 4.256

Review 4.  Molecular biology of the insulin-like growth factors. Relevance to nervous system function.

Authors:  J E Hepler; P K Lund
Journal:  Mol Neurobiol       Date:  1990 Spring-Summer       Impact factor: 5.590

5.  Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa.

Authors:  M Giusti; L Foppiani; P Ponzani; C M Cuttica; M R Falivene; S Valenti
Journal:  J Endocrinol Invest       Date:  1997-05       Impact factor: 4.256

Review 6.  Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands: focus on reproductive system.

Authors:  E Arvat; L Gianotti; R Giordano; F Broglio; M Maccario; F Lanfranco; G Muccioli; M Papotti; A Graziani; E Ghigo; R Deghenghi
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

7.  Receptor autoradiographic analysis of insulin-like growth factor-I (IGF-I) binding sites in rat forebrain and pituitary gland.

Authors:  K Matsuo; M Niwa; M Kurihara; K Shigematsu; S Yamashita; M Ozaki; S Nagataki
Journal:  Cell Mol Neurobiol       Date:  1989-09       Impact factor: 5.046

8.  Release of somatostatin-like immunoreactivity from incubated rat hypothalamus and cerebral cortex. Effects of glucose and glucoregulatory hormones.

Authors:  M Berelowitz; D Dudlak; L A Frohman
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

9.  The effect of thyroid status on the growth hormone response to growth hormone releasing hormone 1-44.

Authors:  R R Davies; S Dagogo-Jack; S J Turner; P Kendall-Taylor; P Baylis; E Young; M Watson; D G Johnston
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

10.  Galanin infusion restores the blunted GH responses to GHRH administration during GH treatment in children with constitutional growth delay.

Authors:  A Sartorio; A Conti; M Monzani; G Faglia
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.